Cholestech fails to avert costly legal battle with Roche
This article was originally published in Clinica
Executive Summary
Roche has served Hayward, California-based Cholestech, with a complaint that it has violated three of its US patents for measuring HDL cholesterol. Although the complaint had been filed in the US District Court of Southern Indiana in March 2003, Roche had held back from serving Cholestech with it while the two companies attempted to negotiate an out-of-court settlement. These talks - which Roche said were aimed at granting a licence to Cholestech - failed.
You may also be interested in...
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.